ReP USP - Resultado da busca

Artigo de periodico
Carcinogenicity of cobalt, antimony compounds, and weapons-grade tungsten alloy (2022)
Karagas, Margaret R; Wang, Amy; Dorman, David C; Hall, Amy L; Pi, Jingbo; Sergi, Consolato M; Symanski, Elaine; Ward, Elizabeth M; Arrandale, Victoria H; Azuma, Kenichi; Brambila, Eduardo; Calaf, Gloria M.; Fritz, Jason M ; Fukushima, Shoji; Gaitens, Joanna M; Grimsrud, Tom K; Guo, Lei; Lynge, Elsebeth; Reis, Amélia P Marinho; McDiarmid, Melissa A; Middleton, Daniel R S; Ong, Thomas Prates
Source: Oncology. Unidade: FCF
Subjects: CARCINOGÊNESE, COBALTO, TUNGSTÊNIO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
KARAGAS, Margaret R et al. Carcinogenicity of cobalt, antimony compounds, and weapons-grade tungsten alloy. Oncology, v. 23, n. 5, p. 577-578, 2022Tradução . . Disponível em: https://doi.org/10.1016/S1470-2045(22)00219-4. Acesso em: 28 maio 2024.
APA
Karagas, M. R., Wang, A., Dorman, D. C., Hall, A. L., Pi, J., Sergi, C. M., et al. (2022). Carcinogenicity of cobalt, antimony compounds, and weapons-grade tungsten alloy. Oncology, 23( 5), 577-578. doi:10.1016/S1470-2045(22)00219-4
NLM
Karagas MR, Wang A, Dorman DC, Hall AL, Pi J, Sergi CM, Symanski E, Ward EM, Arrandale VH, Azuma K, Brambila E, Calaf GM, Fritz JM, Fukushima S, Gaitens JM, Grimsrud TK, Guo L, Lynge E, Reis APM, McDiarmid MA, Middleton DRS, Ong TP. Carcinogenicity of cobalt, antimony compounds, and weapons-grade tungsten alloy [Internet]. Oncology. 2022 ; 23( 5): 577-578.[citado 2024 maio 28 ] Available from: https://doi.org/10.1016/S1470-2045(22)00219-4
Vancouver
Karagas MR, Wang A, Dorman DC, Hall AL, Pi J, Sergi CM, Symanski E, Ward EM, Arrandale VH, Azuma K, Brambila E, Calaf GM, Fritz JM, Fukushima S, Gaitens JM, Grimsrud TK, Guo L, Lynge E, Reis APM, McDiarmid MA, Middleton DRS, Ong TP. Carcinogenicity of cobalt, antimony compounds, and weapons-grade tungsten alloy [Internet]. Oncology. 2022 ; 23( 5): 577-578.[citado 2024 maio 28 ] Available from: https://doi.org/10.1016/S1470-2045(22)00219-4
Artigo de periodico
Is surgery always necessary in rectal cancer? (2014)
Sabbaga, Jorge; Braghiroli, Maria Ignez; Hoff, Paulo M.
Source: Oncology. Unidade: FM
Subjects: NEOPLASIAS RETAIS (CIRURGIA;QUIMIOTERAPIA), PROCEDIMENTOS CIRÚRGICOS OPERATÓRIOS, TERAPIA COMBINADA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SABBAGA, Jorge e BRAGHIROLI, Maria Ignez e HOFF, Paulo M. Is surgery always necessary in rectal cancer?. Oncology, v. 28, n. 7, p. 607-611, 2014Tradução . . Disponível em: http://www.cancernetwork.com/oncology-journal/surgery-always-necessary-rectal-cancer. Acesso em: 28 maio 2024.
APA
Sabbaga, J., Braghiroli, M. I., & Hoff, P. M. (2014). Is surgery always necessary in rectal cancer? Oncology, 28( 7), 607-611. Recuperado de http://www.cancernetwork.com/oncology-journal/surgery-always-necessary-rectal-cancer
NLM
Sabbaga J, Braghiroli MI, Hoff PM. Is surgery always necessary in rectal cancer? [Internet]. Oncology. 2014 ; 28( 7): 607-611.[citado 2024 maio 28 ] Available from: http://www.cancernetwork.com/oncology-journal/surgery-always-necessary-rectal-cancer
Vancouver
Sabbaga J, Braghiroli MI, Hoff PM. Is surgery always necessary in rectal cancer? [Internet]. Oncology. 2014 ; 28( 7): 607-611.[citado 2024 maio 28 ] Available from: http://www.cancernetwork.com/oncology-journal/surgery-always-necessary-rectal-cancer
Artigo de periodico
Five distinct deleted regions on chromosome 17 defining different subsets of human primary breast tumors (1995)
Nagai, Maria Aparecida; Medeiros, A C; Brentani, Maria Mitzi; Brentani, Ricardo Renzo; Marques, L A; Mazoyer, S; Mulligan, L M
Source: Oncology. Unidade: FM
Assunto: ONCOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NAGAI, Maria Aparecida et al. Five distinct deleted regions on chromosome 17 defining different subsets of human primary breast tumors. Oncology, v. no/dec. 1995, n. 6 , p. 448-53, 1995Tradução . . Acesso em: 28 maio 2024.
APA
Nagai, M. A., Medeiros, A. C., Brentani, M. M., Brentani, R. R., Marques, L. A., Mazoyer, S., & Mulligan, L. M. (1995). Five distinct deleted regions on chromosome 17 defining different subsets of human primary breast tumors. Oncology, no/dec. 1995( 6 ), 448-53.
NLM
Nagai MA, Medeiros AC, Brentani MM, Brentani RR, Marques LA, Mazoyer S, Mulligan LM. Five distinct deleted regions on chromosome 17 defining different subsets of human primary breast tumors. Oncology. 1995 ; no/dec. 1995( 6 ): 448-53.[citado 2024 maio 28 ]
Vancouver
Nagai MA, Medeiros AC, Brentani MM, Brentani RR, Marques LA, Mazoyer S, Mulligan LM. Five distinct deleted regions on chromosome 17 defining different subsets of human primary breast tumors. Oncology. 1995 ; no/dec. 1995( 6 ): 448-53.[citado 2024 maio 28 ]
Artigo de periodico
Genetic alterations in c-erb-2 protooncogene as prognostic markers in human primary breast tumors (1993)
Nagai, Maria Aparecida; Marques, L A; Torloni, H; Brentani, Maria Mitzi
Source: Oncology. Unidade: FM
Assunto: ONCOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NAGAI, Maria Aparecida et al. Genetic alterations in c-erb-2 protooncogene as prognostic markers in human primary breast tumors. Oncology, v. 50, n. 6 , p. 412-7, 1993Tradução . . Acesso em: 28 maio 2024.
APA
Nagai, M. A., Marques, L. A., Torloni, H., & Brentani, M. M. (1993). Genetic alterations in c-erb-2 protooncogene as prognostic markers in human primary breast tumors. Oncology, 50( 6 ), 412-7.
NLM
Nagai MA, Marques LA, Torloni H, Brentani MM. Genetic alterations in c-erb-2 protooncogene as prognostic markers in human primary breast tumors. Oncology. 1993 ;50( 6 ): 412-7.[citado 2024 maio 28 ]
Vancouver
Nagai MA, Marques LA, Torloni H, Brentani MM. Genetic alterations in c-erb-2 protooncogene as prognostic markers in human primary breast tumors. Oncology. 1993 ;50( 6 ): 412-7.[citado 2024 maio 28 ]

USP Schools

ReP

Filtros

Authors

Subjects